Follow Us 
US FDA: Now 16 and 17 Year-Olds Can Get Pfizer Vaccine Booster Dose In US | Must Watch
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Pfizer
Pfizer News
Big decision by Donald Trump, halts 100 percent tariff on THIS key product, White House issues statement, US president says...
Victor Dasgupta October 2, 2025 9:56 AM IST
A White House official stated that the process of implementing the tariff will begin, but no new date has been announced.
Top 10 Stocks In Focus Today: Ola Electric, Zomato, IDBI Bank, Pfizer, BSE, L&T, Symphony, NHPC
India.com Business Desk August 21, 2024 8:49 AM IST
L&T Stock: Company announced on Tuesday that the Bombay High Court has nullified a GST demand of Rs 2,237 crore imposed on the company.
Share Price Target Today (21-05-24) Stocks To Buy Today; F&O Stocks; IRCTC, Pfizer, SBI Cards, Oil India, Rites, Whirlpool, Lupin, City Union Bank
Anirudha Yerunkar May 21, 2024 9:25 AM IST
Buy Whirlpool India shares for a target of Rs 1,630 with a stop loss at Rs 1,560
What is mRNA Vaccine? How Does it Help to Fight Against COVID-19?
India.com Lifestyle Staff October 3, 2023 6:12 PM IST
Katalin Kariko and Drew Weissman developed COVID vaccine, mRNA that won the Nobel Prize 2023. Know how mRNA vaccines work and what did the scientists actually find out?
US Health Agency Approves COVID Booster For Age 6 Months And Above Amid Rising Cases, Hospitalization
Analiza Pathak September 13, 2023 7:18 AM IST
Apparently, new Covid-19 variant EG.5 is on the rise in the US. The variant is causing about 17 per cent of the new Covid-19 cases in the country compared to 16 per cent for the next most common lineage, XBB.1.16.
Moderna Sues Pfizer, BioNTech For Copying Its Technology To Develop Covid Vaccine
India.com News Desk August 26, 2022 6:45 PM IST
Moderna in the statement alleged that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology.
Canada Approves 1st COVID Booster For Kids Aged 5-11. Check Details Here
India.com News Desk August 20, 2022 12:09 PM IST
Canada's drug regulator announced it has authorised Pfizer-BioNTech Comirnaty Covid-19 vaccine for use as a booster dose in children aged 5 to 11 years.
US Allows Pharmacists to Prescribe Pfizer s COVID-19 Pill
Associated Press July 7, 2022 11:17 AM IST
Pharmacists can prescribe the leading COVID-19 pill directly to patients under a new U.S. policy announced Wednesday that's intended to expand use of Pfizer's drug Paxlovid.
Tweaked Vaccine Booster Shots Must Target New Relatives Of Omicron Variants
Associated Press July 5, 2022 3:11 PM IST
The Food and Drug Administration (FDA) decided that the boosters needed an update as newer relatives of the Omicron variant have taken over half the Covid-19 infections of the country.
CDC Advisers Recommend COVID-19 Shots For Children Under 5
Associated Press June 19, 2022 12:00 AM IST
The FDA also approved a third dose, at least a month after the second shot, for kids with immune conditions that make them more vulnerable to serious illness.
FDA Advisers Weigh COVID-19 Shots For Babies, Young Children
Associated Press June 15, 2022 11:20 PM IST
Pfizer's submitted data found no safety concerns and suggested that three shots were 80% effective in preventing symptomatic coronavirus infections.
US Likely to Start Covid Vaccination For Children Under 5 Years of Age by June 21. Details Here
IANS June 3, 2022 12:35 PM IST
The Biden administration on Thursday said that children under 5 may be able to get their first COVID-19 vaccination doses as soon as June 21, if federal regulators authorise shots for the age group, as expected.
Raining Jobs As MNCs Set To Hire Over 2,00,000 Employees in India. Deets Inside
India.com News Desk May 18, 2022 11:51 AM IST
Hiring booms in MNCs: Amid the reopening of industries across the spectrum, India-based captive units of multinational companies are also set to increase their headcount.
5 Things To Know About Paxlovid, The Latest COVID Pill 'Strongly Recommended' By WHO
India.com News Desk April 22, 2022 7:43 AM IST
Pfizer's oral treatment prevents hospitalisation more than the "available alternatives", has fewer concerns with respects to harms than molnupiravir, and is easier to administer than intravenous remdesivir and antibodies.
Made In India COVID-19 Vaccines Better Than Pfizer, Moderna: Adar Poonawalla
India.com News Desk April 13, 2022 4:05 PM IST
It's good that vaccines like Pfizer and Moderna are not introduced in India, because in countries like US people have taken the second and third booster dose and still many are getting infected with Corona but in India, our vaccines have given good protection," said Adar Poonawalla.
Additional Covid-19 Boosters For Vulnerable Groups Recommended by US CDC
IANS March 30, 2022 5:24 PM IST
The CDC's move came right after the US Food and Drug Administration (FDA) authorised a second booster dose of either the Pfizer-BioNTech or the Moderna Covid-19 vaccines for these people earlier on Tuesday.
FDA Authorizes Another Pfizer, Moderna COVID Booster For 50 And Up
Associated Press March 29, 2022 10:01 PM IST
Two vaccine doses plus a booster still provide strong protection against severe disease and death, CDC data show.
US to Approve 2nd Vaccine Booster Amid Mixed Pandemic Scenario
IANS March 28, 2022 3:53 PM IST
The authorisations for second Pfizer-BioNTech and Moderna boosters could be announced as soon as next Tuesday, according to US media reports.
Moderna Seeks Emergency Approval For Second Covid Booster For Adults of All Age Group
India.com News Desk March 18, 2022 8:07 AM IST
Covid booster vaccine: Moderna had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.
Pfizer Asks US to Allow 4th COVID Vaccine Dose for Seniors
Associated Press March 16, 2022 7:50 AM IST
The Food and Drug Administration and the Centers for Disease Control would have to approve the request. If so, a key question would be how soon seniors would be advised to roll up their sleeves.
India Didn't Bow To Foreign Vaccine Companies, Health Minister Reveals
India.com News Desk February 18, 2022 10:49 PM IST
Speaking at the launch of Priyam Gandhi-Mody's book 'A Nation to Protect: Leading India Through the Covid Crisis', Union Health Minister Mansukh Mandaviya revealed how India refused to bow to arm-twisting of the foreign vaccine companies during the peak of the COVID-19 pandemic.
Pfizer, BioNTech Seek Emergency Approval Of COVID-19 Vaccine For Kids Under 5 Years Of Age
India.com News Desk February 2, 2022 6:35 AM IST
In December, Pfizer extended its vaccine trial in younger children after two child-sized doses of the vaccine did not produce the expected immunity in 2- to 5-year-olds, although it did so for the babies up to age 2.
Pfizer-BioNTech To Roll Out Omicron-Specific Vaccine Within 2 Months; Begin Clinical Trials
India.com News Desk January 26, 2022 7:21 AM IST
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement.
Omicron Vaccine Expected to be Ready By March: Pfizer
India.com News Desk January 11, 2022 8:30 AM IST
"Vaccine against Omicron will be ready in March. I don't know if we will need it. I don't know if and how it will be used", Pfizer CEO said.
Subscribe Now
Enroll for our free updates